Novartis AG banner

Novartis AG
OTC:NVSEF

Watchlist Manager
Novartis AG Logo
Novartis AG
OTC:NVSEF
Watchlist
Price: 146 USD 3.58% Market Closed
Market Cap: $300.2B

Wall St Price Targets

NVSEF Price Forecast
Based on 27 analysts

+8% Upside
from $146 today

Novartis AG (NVSEF)’s 12-month stock price forecast through September 2027 has a consensus target of $158.16, implying 8% upside. The forecast is based on price targets from 27 Wall Street analysts.

NVSEF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for NVSEF yet.

Novartis AG Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NVSEF's stock price target?
Price Target
158.16 USD

According to Wall Street analysts, the average 1-year price target for NVSEF is 158.16 USD with a low forecast of 125.63 USD and a high forecast of 190.2 USD.

What is the Revenue forecast for Novartis AG?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for Novartis AG?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 4%.

What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.

What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Novartis AG?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.

Back to Top